Table 3.

Efficacy of OG liposome formulations as a function of OG/lipid ratio. Efficacy test against Gonococcus (ATCC 19425, GC 131, DOD 633, UPS 1170, ATCC 49226), Lactobacillus crispatus (ATCC 6099, and 1211), HSV-1 and HSV-2, and HIV-1.

Ratio OG/Lipid	% Lipid	% OG	GC	Lactobacillus	HSV-1	HSV-2	HIV-1 (% Suppression)
0.5	1.0	0.5	×	×	+	+	91
0.2	2.5	0.5	×	/	+	+	87
0.1	5	0.5	×	/	+	+	87
0.05	10	0.5	×	/	+	+	80

× = Killing by showing greater than a 4-log drop compared to control after exposure to the formulation mixture for 30 min.

/ = No killing by showing less than a 4-log drop compared to control after exposure to the formulation mixture for 30 min.

+ = Killing by showing greater than a 3-log drop compared to non-treated control.